Loading...
  • clinical
  • During the Guidelines Meeting in Glasgow November 3rd Marije Hofstra presented the first results on the clinical management of the low level viremia questionnaire. (esar-society.eu)
  • However, the effect of CPLJ treatment on other parameters that could contribute to dengue pathogenesis such as nonstructural protein 1 (NS1) production and viremia level have never been highlighted in any clinical and in vivo studies. (biomedcentral.com)
  • Intensification
  • We investigated whether intensification with the integrase inhibitor raltegravir decreases plasma HIV-1 RNA levels in patients receiving. (oup.com)
  • High-performance liquid chromatography and mass spectroscopy experiments confirmed that therapeutic levels of raltegravir were achieved in plasma during intensification. (oup.com)
  • replication
  • These natural hosts of SIV, like sooty mangabeys, maintain high levels of SIV replication but have evolved to avoid immunodeficiency. (nature.com)
  • failure
  • Lucas Hermans presented findings from an evaluation of low-level viraemia and its impact on ART failure in a large South African cohort managed according to WHO guidelines. (thebodypro.com)
  • The investigators saw a further increase in risk of failure with higher ranges and duration of low-level viraemia. (thebodypro.com)
  • Increased risk of treatment failure after low-level viraemia in a large cohort of South African HIV positive patients treated according to under WHO guidelines. (thebodypro.com)
  • Increased risk of cART failure after low-level viremia under WHO guidelines. (thebodypro.com)
  • Low-level viraemia is linked to treatment failure, but we are failing to make best use of effective HIV treatment as a result of inadequate viral load monitoring. (avert.org)
  • A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure. (eurekalert.org)
  • influence
  • Type of SLA -1 gene profile may correspond with PERVs level in blood and thereby influence on their infectiveness. (vetsci.org)
  • Screening
  • There is a need for multidirectional molecular characterization ( SLA typing, viremia estimation and PERV subtypes screening) of animals intended for xenotransplant research in the interest of xeno-recipients safety. (vetsci.org)
  • samples
  • When comparing the level of total to integrated HIV DNA in these samples we find ES patients have large excesses of unintegrated HIV DNA. (plos.org)
  • impact
  • No significant differences in PERV gag RNA level between transgenic and non-transgenic pigs were noted, likewise the type of applied transgene had no impact on PERV viremia. (vetsci.org)